These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31743040)

  • 1. UCP1-independent glucose-lowering effect of leptin in type 1 diabetes: only in conditions of hypoleptinemia.
    Zouhar P; Rakipovski G; Bokhari MH; Busby O; Paulsson JF; Conde-Frieboes KW; Fels JJ; Raun K; Andersen B; Cannon B; Nedergaard J
    Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E72-E86. PubMed ID: 31743040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Knockout Mice Have Extended Survival but Volatile Blood Glucose Levels on Leptin Therapy.
    Neumann UH; Denroche HC; Mojibian M; Covey SD; Kieffer TJ
    Endocrinology; 2016 Mar; 157(3):1007-12. PubMed ID: 26696124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice.
    Naito M; Fujikura J; Ebihara K; Miyanaga F; Yokoi H; Kusakabe T; Yamamoto Y; Son C; Mukoyama M; Hosoda K; Nakao K
    Diabetes; 2011 Sep; 60(9):2265-73. PubMed ID: 21810600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats.
    Hidaka S; Yoshimatsu H; Kondou S; Tsuruta Y; Oka K; Noguchi H; Okamoto K; Sakino H; Teshima Y; Okeda T; Sakata T
    FASEB J; 2002 Apr; 16(6):509-18. PubMed ID: 11919153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.
    German JP; Wisse BE; Thaler JP; Oh-I S; Sarruf DA; Ogimoto K; Kaiyala KJ; Fischer JD; Matsen ME; Taborsky GJ; Schwartz MW; Morton GJ
    Diabetes; 2010 Jul; 59(7):1626-34. PubMed ID: 20424233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis.
    Perry RJ; Zhang XM; Zhang D; Kumashiro N; Camporez JP; Cline GW; Rothman DL; Shulman GI
    Nat Med; 2014 Jul; 20(7):759-63. PubMed ID: 24929951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin contributes to the beneficial effects of insulin treatment in streptozotocin-diabetic male mice.
    Neumann UH; Kwon MM; Baker RK; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2018 Dec; 315(6):E1264-E1273. PubMed ID: 30300012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupted Leptin Signaling in the Lateral Hypothalamus and Ventral Premammillary Nucleus Alters Insulin and Glucagon Secretion and Protects Against Diet-Induced Obesity.
    Denroche HC; Glavas MM; Tudurí E; Karunakaran S; Quong WL; Philippe M; Britton HM; Clee SM; Kieffer TJ
    Endocrinology; 2016 Jul; 157(7):2671-85. PubMed ID: 27183315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Glucose Uptake and Uncoupling Protein 1 Activity in Adipose Tissue of Diabetic Mice upon β-Adrenergic Stimulation.
    Kubo N; Kawahara M; Okamatsu-Ogura Y; Miyazaki Y; Otsuka R; Fukuchi K
    Mol Imaging Biol; 2019 Apr; 21(2):249-256. PubMed ID: 29987618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of autonomic efferents and uncoupling protein 1 in the glucose-lowering effect of leptin therapy.
    Denroche HC; Kwon MM; Glavas MM; Tudurí E; Philippe M; Quong WL; Kieffer TJ
    Mol Metab; 2016 Aug; 5(8):716-724. PubMed ID: 27656409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade.
    Mani BK; Uchida A; Lee Y; Osborne-Lawrence S; Charron MJ; Unger RH; Berglund ED; Zigman JM
    Diabetes; 2017 Jul; 66(7):1847-1857. PubMed ID: 28487437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glucoregulatory actions of leptin.
    D'souza AM; Neumann UH; Glavas MM; Kieffer TJ
    Mol Metab; 2017 Sep; 6(9):1052-1065. PubMed ID: 28951828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperoxia improves carbohydrate metabolism by browning of white adipocytes in obese type 2 diabetic rats.
    Norouzirad R; Ghanbari M; Bahadoran Z; Abdollahifar MA; Rasouli N; Ghasemi A
    Life Sci; 2019 Mar; 220():58-68. PubMed ID: 30703383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism for leptin's acute insulin-independent effect to reverse diabetic ketoacidosis.
    Perry RJ; Peng L; Abulizi A; Kennedy L; Cline GW; Shulman GI
    J Clin Invest; 2017 Feb; 127(2):657-669. PubMed ID: 28112679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats.
    Cummings BP; Bettaieb A; Graham JL; Stanhope KL; Dill R; Morton GJ; Haj FG; Havel PJ
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14670-5. PubMed ID: 21873226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue.
    Rouru J; Cusin I; Zakrzewska KE; Jeanrenaud B; Rohner-Jeanrenaud F
    Endocrinology; 1999 Aug; 140(8):3688-92. PubMed ID: 10433228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Brown Fat Lipoatrophy Aggravates Atherosclerotic Process in Male Mice.
    Gómez-Hernández A; Beneit N; Escribano Ó; Díaz-Castroverde S; García-Gómez G; Fernández S; Benito M
    Endocrinology; 2016 Sep; 157(9):3517-28. PubMed ID: 27414981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-independent reversal of type 1 diabetes in nonobese diabetic mice with brown adipose tissue transplant.
    Gunawardana SC; Piston DW
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1043-55. PubMed ID: 25898954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes.
    Toyoshima Y; Gavrilova O; Yakar S; Jou W; Pack S; Asghar Z; Wheeler MB; LeRoith D
    Endocrinology; 2005 Sep; 146(9):4024-35. PubMed ID: 15947005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin action in the ventromedial hypothalamic nucleus is sufficient, but not necessary, to normalize diabetic hyperglycemia.
    Meek TH; Matsen ME; Dorfman MD; Guyenet SJ; Damian V; Nguyen HT; Taborsky GJ; Morton GJ
    Endocrinology; 2013 Sep; 154(9):3067-76. PubMed ID: 23782941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.